دورية أكاديمية

Peapod FOS trial: A phase 2 clinical trial of pembrolizumab in combination with carboplatin and cabazitaxel in aggressive variant metastatic castration-resistant prostate cancer.

التفاصيل البيبلوغرافية
العنوان: Peapod FOS trial: A phase 2 clinical trial of pembrolizumab in combination with carboplatin and cabazitaxel in aggressive variant metastatic castration-resistant prostate cancer.
المؤلفون: Esteban Villarrubia, Jorge, Alonso Gordoa, Teresa, Mellado-González, Begoña, Duran, Ignacio, Pinto, Alvaro, Sanchez, Alfredo, Font Pous, Albert, Vazquez-Estevez, Sergio, Puente, Javier, Grande, Enrique, Climent, Miguel Ángel, Maroto-Rey, Pablo, Perez-Gracia, Jose Luis, Ponce Aix, Santiago, Castellano, Daniel, Gonzalez-Billalabeitia, Enrique
المصدر: Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, pTPS238-TPS238, 235p
قاعدة البيانات: Supplemental Index
الوصف
تدمد:0732183X
DOI:10.1200/JCO.2024.42.4_suppl.TPS238